![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 9/32 | |
A61K 9/51 | |||
A61K 9/22 | |||
A61K 9/16 | |||
A61P 35/00 | |||
A61K 9/19 | |||
A61K 9/00 |
(11) | Patento numeris | 2379064 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 09835578.7 |
Europos patento paraiškos padavimo data | 2009-12-15 | |
(97) | Europos patento paraiškos paskelbimo data | 2011-10-26 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-26 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2009/068028 |
Data | 2009-12-15 |
(87) | Numeris | WO 2010/075072 |
Data | 2010-07-01 |
(30) | Numeris | Data | Šalis |
260200 P | 2009-11-11 | US | |
249022 P | 2009-10-06 | US | |
122479 P | 2008-12-15 | US |
(72) |
ZALE, Stephen, E., US
TROIANO, Greg, US
ALI, Mir, Mukkaram, US
HRKACH, Jeff, US
WRIGHT, James, US
LOW, Susan, US
|
(73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017-5755,
US
|
(54) | LONG CIRCULATING NANOPARTICLES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS |
LONG CIRCULATING NANOPARTICLES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS |